Zeposia 0.92 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FV692
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,479
Award facts
- Contract value 100% obligated
- $19,479.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $19,479 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 21, 2026, for the supply of Zeposia 0.92 mg capsules (30-count units). This is a non-set-aside, competitively awarded contract with performance through February 11, 2026, and work to be performed at the awardee's facility in Conshohocken, Pennsylvania. Zeposia is a prescription medication used in the treatment of multiple sclerosis and ulcerative colitis, reflecting the Defense Logistics Agency's ongoing need to supply pharmaceutical products to military healthcare systems and veteran programs.
This delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc.'s, larger Indefinite Delivery Contract with the Defense Logistics Agency's Troop Support Medical division. This prime IDC, valued at $999,999,999 through December 2031, serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of a broad range of brand-name and generic medications, specialty drugs, vaccines, and medical supplies to support military healthcare programs worldwide. The structure demonstrates the Defense Logistics Agency's reliance on major pharmaceutical distributors to efficiently fulfill critical medical supply requirements across the federal health system.
Quick answers
Who was awarded contract SPE2DR26FV692?
SPE2DR26FV692 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FV692 worth?
The government has obligated $19,479 on SPE2DR26FV692.
Is contract SPE2DR26FV692 an order under another contract?
Yes. SPE2DR26FV692 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV692 competed?
The extent of competition for SPE2DR26FV692 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award